Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2023-07-03 M&A Activity
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
OFFRE RECOMMANDÉE EN ESPÈCES par Novacyt UK Holdings Limited pour Yourgene Health plc
M&A Activity Classification · 99% confidence The document is a formal announcement dated July 3, 2023, detailing a recommended all-cash offer by Novacyt UK Holdings Limited for the entire share capital of Yourgene Health plc. It outlines the terms of the acquisition (0.522 pence per share), the rationale (strategic fit, synergy creation), the recommendation from the Yourgene board, and irrevocable undertakings from major shareholders. The structure, language, and content (offer price, premium calculation, use of a 'scheme of arrangement' under the Companies Act 2006) are characteristic of a formal takeover or merger announcement. This aligns directly with the definition for M&A Activity (TAR).
2023-07-03 French
Notice of rescheduled AGM
AGM Information Classification · 99% confidence The document explicitly announces a 'Notice of rescheduled AGM' (Annual General Meeting) for Novacyt S.A. It details the new date (Thursday 10 August), location (Paris), and the reason for rescheduling (failure to meet quorum). This content directly relates to the materials and announcements surrounding the Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information). The presence of the RNS Number and the closing boilerplate confirms it is a regulatory announcement, but the core subject matter dictates the specific type.
2023-06-15 English
Avis de seconde convocation à l’Assemblée Générale Annuelle
AGM Information Classification · 99% confidence The document is explicitly titled "Avis de seconde convocation à l'Assemblée Générale Annuelle" (Notice of second call for the Annual General Meeting). It discusses the rescheduling of the AGM due to lack of quorum and provides details for shareholders on how to attend and vote. This content directly relates to the procedures and announcements surrounding the Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information). The document length (5024 chars) is substantial enough that it is not merely a brief announcement of a report (RPA/RNS), but the substantive notice itself.
2023-06-15 French
Reminder to shareholders re. AGM voting
AGM Information Classification · 98% confidence The document text explicitly mentions 'annual general meeting (AGM)' multiple times, discusses encouraging shareholders to 'submit their votes in advance', and details the process for voting and attending the meeting. The RNS Number indicates it is a regulatory announcement. Since the content is focused on providing information and reminders related to the upcoming AGM and shareholder voting procedures, the most appropriate classification is AGM Information (AGM-R). Although it relates to voting, it is a reminder/information piece about the meeting itself, rather than the official declaration of voting results (DVA).
2023-06-12 English
Liquidity Agreement and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details a 'Liquidity Agreement Monthly Update' concerning share purchases/sales under that agreement and provides the 'Total Voting Rights' as of May 31, 2023. This type of routine, mandatory disclosure, often related to share capital management or administrative updates, fits best under the general regulatory announcement category, especially since it is not a primary financial report (like 10-K or IR) or a specific event announcement (like DIV or DIRS). Given the options, 'Regulatory Filings' (RNS) is the most appropriate general classification for this type of LSE-distributed announcement that doesn't fit a more specific operational or financial category.
2023-06-01 English
Information mensuelle sur le contrat de liquidite et sur le nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote" (Monthly information on the liquidity contract and on the total number of voting rights). It details the monthly activity (purchases and sales of shares) under a liquidity contract managed by Invest Securities for the period May 1 to May 31, 2023. It also reports the total number of voting rights. This type of regular, periodic disclosure concerning share transactions (often related to buybacks or market making) and share capital structure updates is most closely aligned with announcements related to capital structure changes or specific regulatory disclosures. Since it specifically details transactions under a liquidity contract (which often involves share repurchase/dealing) and provides the total share count for voting purposes, it fits best under 'Transaction in Own Shares' (POS) or potentially 'Share Issue/Capital Change' (SHA). Given the focus on the liquidity contract execution (buying/selling shares), 'POS' (Transaction in Own Shares) is the most precise fit, as liquidity contracts often involve the agent buying shares to be held as treasury stock or cancelled, which falls under the scope of share transactions by the company (even if executed by a third party under mandate). It is not a full financial report (10-K, IR) or a general earnings release (ER).
2023-06-01 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.